Claritev (CTEV) financial statements

Healthcare · Health Information Services · Market cap $215M

Claritev reported revenue of $965M in fiscal 2025, down 1.1% a year over 7 years.

Net income was -$284M and the operating margin 3.0%, against 41.1% in 2018.

Free cash flow was -$12M.

The diluted share count rose 58% over the period (dilution).

Revenue and free cash flow

Fiscal years, $ billions.

-0.500.511.520182019202020212022202320242025RevenueFree cash flow
Embed this chart

Free to use in articles and newsletters with the source line. Paste this HTML:

Income statement

Fiscal years, from Claritev's 10-K filings with the SEC.

Fiscal year20182019202020212022202320242025
Revenue$1.0B$983M$938M$1.1B$1.1B$962M$931M$965M
Cost of revenue$149M$150M$319M$175M$204M$235M$239M$253M
Gross profit$891M$833M$619M$942M$876M$726M$691M$712M
Selling, general and admin$78M$75M$356M$151M$167M$143M$151M$222M
Operating income$428M$368M-$132M$386M-$363M$162M-$1.4B$29M
Interest expense$383M$376M$336M$267M$303M$333M$326M$392M
Pre-tax income$10M-$547M$136M$135M-$561M-$107M-$1.8B-$373M
Income tax$800,000-$26M$33M$33M$12M-$15M-$125M-$89M
Net income$36M$10M-$521M$102M-$573M-$92M-$1.6B-$284M
EPS (diluted)$3.60$0.80-$44.40$6.40-$36.00-$5.69-$101.92-$17.30
Diluted shares10M10M12M16M16M16M16M16M
Gross margin85.6%84.8%66.0%84.3%81.1%75.5%74.3%73.8%
Operating margin41.1%37.5%-14.1%34.5%-33.6%16.8%-149.4%3.0%
Net margin3.5%1.0%-55.5%9.1%-53.1%-9.5%-176.9%-29.4%

Balance sheet

Fiscal years, from Claritev's 10-K filings with the SEC.

Fiscal year20182019202020212022202320242025
Cash and short-term investments$5M$22M$127M$185M$334M$72M$17M$17M
Receivables—$77M$63M$100M$79M$77M$90M$128M
Total current assets—$116M$209M$319M$447M$194M$176M$224M
Property, plant and equipment—$178M$188M$213M$233M$267M$293M$326M
Goodwill$4.1B$4.1B$4.3B$4.4B$3.7B$3.8B$2.4B$2.4B
Total assets—$8.4B$8.3B$8.2B$7.4B$7.0B$5.2B$4.9B
Total current liabilities—$86M$112M$142M$176M$167M$214M$261M
Long-term debt—$5.4B$4.6B$4.9B$4.7B$4.5B$4.5B$4.6B
Total liabilities—$6.4B$5.7B$5.9B$5.6B$5.3B$5.1B$5.1B
Shareholders' equity$2.0B$2.0B$2.6B$2.3B$1.8B$1.7B$84M-$174M
Net debt-$5M$5.4B$4.5B$4.7B$4.4B$4.5B$4.5B$4.6B

Cash flow

Fiscal years, from Claritev's 10-K filings with the SEC.

Fiscal year20182019202020212022202320242025
Operating cash flow$292M$284M$377M$405M$372M$172M$108M$117M
Capital spending$64M$66M$71M$85M$90M$109M$118M$130M
Free cash flow$229M$218M$307M$320M$283M$63M-$11M-$12M
Stock-based compensation$5M-$15M$406M$18M$17M$18M$27M$28M
Share buybacks (net)$0$0-$101M-$100M$0-$15M-$10M$0
Free cash flow margin22.0%22.2%32.7%28.6%26.2%6.5%-1.1%-1.3%
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for CTEV.
Open CTEV in Investingly

Questions

What was Claritev's revenue in 2025?

$965M in fiscal 2025, from its 10-K filing.

How much free cash flow does Claritev generate?

-$12M in fiscal 2025 (operating cash flow minus capital spending).

From Claritev's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.